274 related articles for article (PubMed ID: 20051606)
1. Ageing, neurodegeneration and Parkinson's disease.
Hindle JV
Age Ageing; 2010 Mar; 39(2):156-61. PubMed ID: 20051606
[TBL] [Abstract][Full Text] [Related]
2. Alpha-synuclein pathology in Parkinson's and Alzheimer's disease brain: incidence and topographic distribution--a pilot study.
Jellinger KA
Acta Neuropathol; 2003 Sep; 106(3):191-201. PubMed ID: 12845452
[TBL] [Abstract][Full Text] [Related]
3. Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease.
Orimo S; Uchihara T; Nakamura A; Mori F; Kakita A; Wakabayashi K; Takahashi H
Brain; 2008 Mar; 131(Pt 3):642-50. PubMed ID: 18079166
[TBL] [Abstract][Full Text] [Related]
4. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease.
Halliday GM; Ophof A; Broe M; Jensen PH; Kettle E; Fedorow H; Cartwright MI; Griffiths FM; Shepherd CE; Double KL
Brain; 2005 Nov; 128(Pt 11):2654-64. PubMed ID: 16000336
[TBL] [Abstract][Full Text] [Related]
5. The progression of pathology in Parkinson's disease.
Halliday GM; McCann H
Ann N Y Acad Sci; 2010 Jan; 1184():188-95. PubMed ID: 20146698
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of Parkinson's disease linked to pathological alpha-synuclein: new targets for drug discovery.
Lee VM; Trojanowski JQ
Neuron; 2006 Oct; 52(1):33-8. PubMed ID: 17015225
[TBL] [Abstract][Full Text] [Related]
7. How to diagnose dementia with Lewy bodies: state of the art.
Geser F; Wenning GK; Poewe W; McKeith I
Mov Disord; 2005 Aug; 20 Suppl 12():S11-20. PubMed ID: 16092075
[TBL] [Abstract][Full Text] [Related]
8. A critical reappraisal of current staging of Lewy-related pathology in human brain.
Jellinger KA
Acta Neuropathol; 2008 Jul; 116(1):1-16. PubMed ID: 18592254
[TBL] [Abstract][Full Text] [Related]
9. Research in motion: the enigma of Parkinson's disease pathology spread.
Brundin P; Li JY; Holton JL; Lindvall O; Revesz T
Nat Rev Neurosci; 2008 Oct; 9(10):741-5. PubMed ID: 18769444
[TBL] [Abstract][Full Text] [Related]
10. Neurodegeneration in normal brain aging and disease.
Thal DR; Del Tredici K; Braak H
Sci Aging Knowledge Environ; 2004 Jun; 2004(23):pe26. PubMed ID: 15190177
[TBL] [Abstract][Full Text] [Related]
11. Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation.
Tong J; Wong H; Guttman M; Ang LC; Forno LS; Shimadzu M; Rajput AH; Muenter MD; Kish SJ; Hornykiewicz O; Furukawa Y
Brain; 2010 Jan; 133(Pt 1):172-88. PubMed ID: 19903734
[TBL] [Abstract][Full Text] [Related]
12. Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease.
Dickson DW; Fujishiro H; DelleDonne A; Menke J; Ahmed Z; Klos KJ; Josephs KA; Frigerio R; Burnett M; Parisi JE; Ahlskog JE
Acta Neuropathol; 2008 Apr; 115(4):437-44. PubMed ID: 18264713
[TBL] [Abstract][Full Text] [Related]
13. [Parkinson's disease, dementia with Lewy bodies, multiple system atrophy and alpha-synuclein].
Iwatsubo T
Rinsho Shinkeigaku; 1999 Dec; 39(12):1285-6. PubMed ID: 10791099
[TBL] [Abstract][Full Text] [Related]
14. Alteration in alpha-synuclein mRNA expression in Parkinson's disease.
Kingsbury AE; Daniel SE; Sangha H; Eisen S; Lees AJ; Foster OJ
Mov Disord; 2004 Feb; 19(2):162-70. PubMed ID: 14978671
[TBL] [Abstract][Full Text] [Related]
15. Relative preservation of thalamic centromedian nucleus in parkinsonian patients with dystonia.
Truong L; Brooks D; Amaral F; Henderson JM; Halliday GM
Mov Disord; 2009 Oct; 24(14):2128-35. PubMed ID: 19735086
[TBL] [Abstract][Full Text] [Related]
16. Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease.
Conway KA; Harper JD; Lansbury PT
Nat Med; 1998 Nov; 4(11):1318-20. PubMed ID: 9809558
[TBL] [Abstract][Full Text] [Related]
17. [Incidental occurrence of Lewy bodies in the brains of elderly patients--the relevance to aging and Parkinson's disease].
Wakabayashi K; Takahashi H; Oyanagi K; Ikuta F
No To Shinkei; 1993 Nov; 45(11):1033-8. PubMed ID: 8135950
[TBL] [Abstract][Full Text] [Related]
18. Clinical evaluation of Parkinson's disease dementia: association with aging and visual hallucination.
Kitayama M; Wada-Isoe K; Nakaso K; Irizawa Y; Nakashima K
Acta Neurol Scand; 2007 Sep; 116(3):190-5. PubMed ID: 17714333
[TBL] [Abstract][Full Text] [Related]
19. Dementia with Lewy bodies.
Lennox GG; Lowe JS
Baillieres Clin Neurol; 1997 Apr; 6(1):147-66. PubMed ID: 9426873
[TBL] [Abstract][Full Text] [Related]
20. Environmental neurotoxic chemicals-induced ubiquitin proteasome system dysfunction in the pathogenesis and progression of Parkinson's disease.
Sun F; Kanthasamy A; Anantharam V; Kanthasamy AG
Pharmacol Ther; 2007 Jun; 114(3):327-44. PubMed ID: 17521740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
